Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
National Vision Holdings, Inc. stock logo
EYE
National Vision
$24.21
-0.2%
$23.05
$9.56
$25.67
$1.92B1.271.91 million shs1.81 million shs
Glaukos Corporation stock logo
GKOS
Glaukos
$86.39
+0.3%
$97.99
$77.10
$163.71
$4.92B0.781.10 million shs1.51 million shs
Envista Holdings Corporation stock logo
NVST
Envista
$20.78
+10.0%
$19.41
$14.22
$23.00
$3.20B12.23 million shs6.20 million shs
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€25.14
+1.7%
€24.37
€17.12
€28.00
€7.61B0.55337,123 shs551,500 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
National Vision Holdings, Inc. stock logo
EYE
National Vision
-0.21%-3.24%+0.21%+84.25%+67.43%
Glaukos Corporation stock logo
GKOS
Glaukos
+0.37%-8.37%-16.67%-1.38%-26.28%
Envista Holdings Corporation stock logo
NVST
Envista
+10.03%-0.12%+2.97%+22.45%+21.73%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
+1.91%-3.97%+2.53%+17.86%+21.57%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.8527 of 5 stars
2.32.00.03.33.40.80.0
Glaukos Corporation stock logo
GKOS
Glaukos
3.9745 of 5 stars
3.42.00.04.42.61.70.6
Envista Holdings Corporation stock logo
NVST
Envista
3.5854 of 5 stars
2.22.00.03.83.80.01.9
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
1.9479 of 5 stars
0.04.00.80.02.80.01.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.60
Moderate Buy$24.18-0.12% Downside
Glaukos Corporation stock logo
GKOS
Glaukos
2.85
Moderate Buy$127.4247.49% Upside
Envista Holdings Corporation stock logo
NVST
Envista
2.33
Hold$20.920.69% Upside
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
2.86
Moderate BuyN/AN/A

Current Analyst Ratings Breakdown

Latest EYE, NVST, STVN, and GKOS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/1/2025
Envista Holdings Corporation stock logo
NVST
Envista
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$24.00 ➝ $25.00
8/1/2025
Envista Holdings Corporation stock logo
NVST
Envista
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderperform ➝ Underperform$15.00 ➝ $18.00
8/1/2025
Envista Holdings Corporation stock logo
NVST
Envista
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$17.00 ➝ $19.00
8/1/2025
Envista Holdings Corporation stock logo
NVST
Envista
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$16.00 ➝ $17.00
8/1/2025
Envista Holdings Corporation stock logo
NVST
Envista
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$17.00 ➝ $19.00
7/31/2025
Glaukos Corporation stock logo
GKOS
Glaukos
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$130.00
7/31/2025
Glaukos Corporation stock logo
GKOS
Glaukos
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
7/31/2025
Glaukos Corporation stock logo
GKOS
Glaukos
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$86.00 ➝ $92.00
7/31/2025
Glaukos Corporation stock logo
GKOS
Glaukos
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$125.00 ➝ $134.00
7/30/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$36.00
7/29/2025
Envista Holdings Corporation stock logo
NVST
Envista
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$18.00 ➝ $22.00
(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
National Vision Holdings, Inc. stock logo
EYE
National Vision
$1.82B1.05$1.63 per share14.83$10.37 per share2.33
Glaukos Corporation stock logo
GKOS
Glaukos
$432.95M11.40N/AN/A$13.39 per share6.45
Envista Holdings Corporation stock logo
NVST
Envista
$2.51B1.40$1.83 per share11.37$17.05 per share1.22
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€1.12B6.77€0.77 per share32.73€5.02 per share5.01
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
National Vision Holdings, Inc. stock logo
EYE
National Vision
-$28.50M-$0.33N/A89.673.44-1.40%3.44%1.40%8/6/2025 (Estimated)
Glaukos Corporation stock logo
GKOS
Glaukos
-$146.37M-$1.65N/AN/AN/A-21.43%-8.59%-6.61%N/A
Envista Holdings Corporation stock logo
NVST
Envista
-$1.12B-$6.5364.9417.171.192.11%4.89%2.71%N/A
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€127.45M€0.5149.3043.342.4811.14%10.00%6.03%8/5/2025 (Confirmed)

Latest EYE, NVST, STVN, and GKOS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
$0.12N/AN/AN/A$469.21 millionN/A
7/31/2025Q2 2025
Envista Holdings Corporation stock logo
NVST
Envista
$0.24$0.26+$0.02$0.16$638.21 million$682.10 million
7/30/2025Q2 2025
Glaukos Corporation stock logo
GKOS
Glaukos
-$0.26-$0.24+$0.02-$0.34$115.49 million$124.12 million
5/7/2025Q1 2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
$0.32$0.34+$0.02$0.18$510.30 million$510.32 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/AN/AN/AN/AN/A
Glaukos Corporation stock logo
GKOS
Glaukos
N/AN/AN/AN/AN/A
Envista Holdings Corporation stock logo
NVST
Envista
N/AN/AN/AN/AN/A
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/AN/AN/AN/A1 Years

Latest EYE, NVST, STVN, and GKOS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/2/2025
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
annual€0.060.3%6/5/20256/5/20257/17/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
National Vision Holdings, Inc. stock logo
EYE
National Vision
0.29
0.54
0.35
Glaukos Corporation stock logo
GKOS
Glaukos
0.09
5.51
5.62
Envista Holdings Corporation stock logo
NVST
Envista
0.43
2.12
1.82
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.22
1.83
1.26

Institutional Ownership

CompanyInstitutional Ownership
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/A
Glaukos Corporation stock logo
GKOS
Glaukos
99.04%
Envista Holdings Corporation stock logo
NVST
Envista
N/A
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/A

Insider Ownership

CompanyInsider Ownership
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.70%
Glaukos Corporation stock logo
GKOS
Glaukos
5.80%
Envista Holdings Corporation stock logo
NVST
Envista
1.30%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
National Vision Holdings, Inc. stock logo
EYE
National Vision
13,41179.05 million76.92 millionOptionable
Glaukos Corporation stock logo
GKOS
Glaukos
78057.14 million53.83 millionOptionable
Envista Holdings Corporation stock logo
NVST
Envista
12,300169.49 million167.28 millionOptionable
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
5,521302.84 million300.72 millionOptionable

Recent News About These Companies

Stevanato Group SpA (STVN) - Investing.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
National Vision stock logo

National Vision NASDAQ:EYE

$24.21 -0.05 (-0.21%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$24.20 -0.01 (-0.04%)
As of 08/1/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

Glaukos stock logo

Glaukos NYSE:GKOS

$86.39 +0.30 (+0.35%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$86.16 -0.23 (-0.27%)
As of 08/1/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Envista stock logo

Envista NYSE:NVST

$20.78 +1.89 (+10.01%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$20.80 +0.02 (+0.07%)
As of 08/1/2025 06:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Stevanato Group stock logo

Stevanato Group NYSE:STVN

€25.14 +0.43 (+1.74%)
As of 08/1/2025 03:59 PM Eastern

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.